Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Peer Support Workers Study

29 października 2026 zaktualizowane przez: Jessica Moe, University of British Columbia

Creating Safety in Chaos: Integrating Peer Support Workers in Emergency Departments to Support Patients Who Use Substances and Opioids

Many people with high-risk opioid use visit emergency departments (EDs), facing a high risk of death if they leave before completing care. Peer support workers (Peers) - people with lived experience of substance use - may improve patient comfort, reduce early departures, and potentially lower mortality rates. This study aims to evaluate how a hospital-implemented ED Peer program can enhance patient support, reduce barriers to care, and provide harm-reduction resources in a person-centred and trauma-informed manner. The study will assess whether Peer availability and direct Peer-patient interactions are associated with improved ED care outcomes, including reduced leaving before treatment completion, as well as subsequent healthcare utilization, overdose, mortality, and other relevant patient outcomes.

Przegląd badań

Szczegółowy opis

The study was initially designed as a feasibility evaluation of the ED Peer program and of the use of a randomized shift schedule to assign Peer availability. As program implementation progressed and staffing stabilized, the evaluation framework was refined to examine both the effect of Peer availability and outcomes associated with direct Peer-patient interaction.

From 23 November 2024 through 16 October 2025, Peer availability was assigned according to an a priori randomized shift schedule developed in collaboration with human resources and ED operational leadership. Following achievement of full Peer staffing, the program transitioned to routine clinical operation.

The study has two main analytic objectives: 1) during the shift-randomization period, investigators will compare outcomes between shifts with and without scheduled Peer availability among patients presenting with substance use-related concerns; 2) investigators will evaluate outcomes associated with direct Peer-patient interaction by comparing patients who interacted with a Peer with comparable patients who did not interact with a Peer.

The primary outcome is leaving before treatment completion (LBTC). Additional outcomes will include measures of ED care, subsequent healthcare utilization, substance use treatment, overdose, mortality, and other relevant clinical and health-service outcomes.

Investigators will request routinely collected records for Vancouver General Hospital ED visits during the study period. Records of eligible ED patients presenting during the study period will be linked to provincial administrative data to evaluate outcomes. Data sources will include the National Ambulatory Care Reporting System (NACRS), Discharge Abstract Database (DAD), Vital Statistics, PharmaNet, Medical Services Plan (MSP), and the Central Demographics File. Population Data BC and Health Data Platform BC will support secure data linkage, and additional relevant datasets may be explored where useful to the study objectives.

These data will support cohort definition, construction of comparison groups, development of propensity scores, sensitivity analyses, and evaluation of outcomes including receipt of ED treatments and referrals, ED revisits, hospitalizations, overdose, opioid agonist therapies and other addiction treatments, mortality, and other relevant health-service outcomes.

Investigators will also obtain records of security-related events occurring during ED visits over the study period. These data will be used to examine whether Peer availability is associated with differences in events such as need for de-escalation or other security involvement.

Typ studiów

Interwencyjne

Zapisy (Szacowany)

3781

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

Kopia zapasowa kontaktu do badania

Lokalizacje studiów

    • British Columbia
      • Vancouver, British Columbia, Kanada, V5Z 1M9
        • Rekrutacyjny
        • Vancouver General Hospital
        • Kontakt:

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat i starsze (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  • Emergency Department (ED) patient at Vancouver General Hospital (VGH)
  • Age 18 years or older
  • Identified as using substances
  • Able to receive or decline peer support services during the ED visit

Exclusion Criteria:

  • Under 18 years of age
  • Does not report substance use

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie podtrzymujące
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Brak (otwarta etykieta)

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Peer Support Intervention

Investigators will evaluate the Peer Support intervention using two analytical approaches:

  1. Primary Analysis (Intention-to-Treat): Peer Available Shift Patients who presented to the emergency department (ED) with substance use-related complaints during shifts when a Peer support worker was scheduled to be available, according to an a priori randomized schedule. Patients may or may not have directly interacted with a Peer during their ED visit. All eligible patients will be analyzed according to their randomized shift assignment, regardless of whether a direct Peer-patient interaction occurred.
  2. Secondary Analysis: Interacted With Peer Patients who presented to the ED with substance use-related concerns and directly interacted with a Peer support worker during their ED visit. Peer activities may have included harm reduction support, provision of naloxone and sterile drug use supplies, linkage to substance use treatment, and connections to follow-up care and community resources.

During intervention shifts, Peer support workers were scheduled to be available in the emergency department to provide support to patients with substance use-related concerns. Peer support workers offered services tailored to individual patients' needs, including referrals to clinical and social support services (e.g., social work, addictions specialists, Indigenous patient navigators, and community-based addiction services), provision of resources (e.g., blankets, food, naloxone kits, sterile drug use supplies, and information brochures), emotional support, and communication support between patients and healthcare providers regarding patients' conditions and ED care. The primary analysis will evaluate the effect of randomized Peer availability using an intention-to-treat approach. The secondary analysis will evaluate outcomes associated with actual Peer-patient interactions by comparing patients who received Peer support with comparable patients who did not.

Brak interwencji: No Peer Support Intervention

Investigators will define the comparison group using two approaches:

  1. Primary Analysis (Intention-to-Treat): No Peer Available Shift Patients presenting to the ED with substance use-related complaints during shifts randomized to no Peer availability.
  2. Secondary Analysis: Did Not Interact With Peer Patients presenting with similar substance use-related complaints who did not directly interact with a Peer. Investigators will use propensity score weighting to improve comparability with patients who received Peer support. The model will include relevant covariates (e.g., age, sex, area-level deprivation, prior substance use-related ED visits and hospitalizations, and prescriptions for substance dependence medications recorded in PharmaNet during the previous 12 months).

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Leaving Before Treatment Completion (LBTC)
Ramy czasowe: From enrollment through 12 months of follow-up

Investigators will measure LBTC among ED patients with substance use-related complaints (e.g., substance withdrawal, misuse/intoxication, overdose, and localized swelling/redness).

Investigators will evaluate LBTC using two approaches:

  1. Primary Analysis (Intention-to-Treat): Peer vs. No Peer Shifts Investigators will classify eligible ED visits based on the randomized Peer schedule. For each shift, investigators will calculate the percentage of eligible visits resulting in LBTC. Linear regression will be used to compare LBTC percentages between Peer and No Peer shifts, regardless of actual Peer interaction.
  2. Secondary Analysis: Peer Interaction vs. No Peer Interaction Investigators will use propensity score weighting to improve comparability between patients who interacted with a Peer and those who did not. Mixed-effects logistic regression will be used to compare LBTC probabilities between groups, accounting for clustering by shift and adjusting for relevant covariates.
From enrollment through 12 months of follow-up

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Distribution of randomized Peer shifts by day of week (feasibility outcome)
Ramy czasowe: From study initiation to achievement of full Peer staffing, approximately one year

Assessed by examining the distribution of scheduled Peer shifts across each day of the week over the 48-week randomized schedule period. The schedule was developed in collaboration with human resources and ED operational leadership and approved as meeting hospital employee policy. The randomization approach used block-based scheduling with built-in constraints (e.g., mandatory weekends off). This outcome evaluates whether the resulting schedule achieved a balanced weekday/weekend distribution.

Unit of Measure: Number and percentage of Peer shifts scheduled per day of the week

From study initiation to achievement of full Peer staffing, approximately one year
ED-based substance use and harm reduction interventions
Ramy czasowe: Baseline

Secondary outcomes will include receipt of naloxone kits, opioid agonist therapy doses, and withdrawal treatments during the ED visit. Investigators will compare counts of these outcomes between intervention (Peer) and control (no Peer) groups using multivariable count regression. Investigators will assess clustering of outcomes by shift and adjust for the same covariates included in the primary analysis.

Baseline
30-day health care utilization and clinical events (e.g., drug poisoning, mortality)
Ramy czasowe: From enrollment through 30 days of follow-up from ED visit

Exploratory outcomes will include ED visits, hospitalizations, drug poisoning, and mortality within 30 days following the index ED visit. Investigators will analyze counts of these events using multivariable count regression, with the log-transformed length of follow-up included as an offset term where applicable, and will conduct time-to-event analyses using Cox regression. Investigators will assess clustering of outcomes by shift and adjust for the same covariates included in the primary analysis.

From enrollment through 30 days of follow-up from ED visit
Security-related events during ED visits
Ramy czasowe: Baseline

Investigators will obtain records of security-related events occurring during ED visits over the study period from the ED security event database. Investigators will assess whether Peer availability was associated with differences in the frequency and type of security-related events, including escalation events and incidents requiring security involvement.

Baseline
Thematic summary of Indigenous patients' experiences with the Peer program
Ramy czasowe: Within 6 months after the patient's ED visit involving Peer interaction

Indigenous patient perspectives on the Peer program will be collected through surveys, culturally grounded storytelling and sharing circles. Sessions will be guided by open-ended questions to explore perceived safety, support, and emotional impact of Peer involvement in the emergency department. Transcripts will be analyzed using Indigenous-informed thematic analysis to identify key insights and priorities for culturally safe care.

Unit of Measure: Themes and narratives identified through qualitative analysis

Within 6 months after the patient's ED visit involving Peer interaction
Thematic summary of healthcare providers' perceptions of the Peer program assessed through focus groups
Ramy czasowe: From 12-24 months after Peer program implementation

Acceptability of the Peer program among healthcare providers will be evaluated using semi-structured focus groups conducted periodically post-implementation. Discussions will explore perceived value, observed patient impact, integration into ED workflows, challenges, and suggestions for improvement. Audio recordings will be transcribed and analyzed using thematic content analysis to identify recurring patterns and representative quotes.

Unit of Measure: Thematic categories identified through qualitative analysis

From 12-24 months after Peer program implementation
Thematic summary of PWLLE perceptions and experiences of the Peer program assessed through focus groups
Ramy czasowe: From 12-24 months after Peer program implementation

Perspectives of people with lived and living experience (PWLLE) on the Peer program will be evaluated using semi-structured focus groups. Discussions will explore participants' perceptions of the value and accessibility of Peer support, experiences of substance use-related care in the ED, perceived impacts of the Peer program, barriers and gaps in care, and suggestions for improving Peer support and program delivery. Audio recordings will be transcribed and analyzed using thematic content analysis to identify recurring themes and representative quotes. Unit of Measure: Thematic categories identified through qualitative analysis

From 12-24 months after Peer program implementation
Acceptability of the Peer program evaluated through periodic surveys
Ramy czasowe: From 12-24 months after Peer program implementation

Acceptability and implementation of the Peer program will be assessed through periodic surveys administered to Peers, patients accessing Peer services, members of the ED buprenorphine/naloxone team, and multidisciplinary healthcare providers. Surveys will assess experiences with the Peer program, including perceived value, respect, ease of communication, clarity of information, comfort, confidentiality, teamwork, integration into ED workflows, and perceived facilitators and barriers to implementation.

From 12-24 months after Peer program implementation

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Śledczy

  • Główny śledczy: Jessica Moe, MD, University of British Columbia

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

23 listopada 2024

Zakończenie podstawowe (Szacowany)

1 marca 2028

Ukończenie studiów (Szacowany)

1 grudnia 2028

Daty rejestracji na studia

Pierwszy przesłany

3 czerwca 2025

Pierwszy przesłany, który spełnia kryteria kontroli jakości

11 czerwca 2025

Pierwszy wysłany (Rzeczywisty)

22 czerwca 2025

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

3 listopada 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

29 października 2026

Ostatnia weryfikacja

1 października 2026

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • H24-03008
  • F26-03530 (Inny numer grantu/finansowania: Health Canada)
  • F25-02658 (Inny numer grantu/finansowania: Vancouver Coastal Health Research Institute)

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIE

Opis planu IPD

There is no plan to make individual participant data available to other researchers

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj